FDA Investigator Lewis K Antwi

Lewis K Antwi has inspections in 5 countries as of 25 Oct 2023. Lewis K Antwi has collaborated with a combinined 4984 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
127
Last Inspection Date:
25 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100008860
Country:
United States of America, France, Belgium, Italy, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Abby Lmozeke Baker, Abdur Razzaque, Adam J Taylor, Aditi S Thakur, Aikaterini Alexaki, Alanna Lmussawwir Bias, Amanda L Baskin, Amanda S Zorn, Amina Bashir, Andrea D Swingle, Andrew Byrnes, PhD, Andrew J Barrowcliff, Angela J Alexander, Angela K Shen, Angela S Whatley, Anissa M Cheung, Antonio M Hampton, Arie C Menachem, Ava M Bowman, Barbara A Rusin, Barbara G Peoples, Benjamin J Smith, Bernard P Heidt, Bharat Khurana, Bradley J Maunder, Brandi N Mcgrady, Brenda C Hamilton, Brenda L Reihing, Brent T Hall, Brentley S Collins, Brian J Davis, Brittany M Lowe, Bruce, Bryan A Galvez, Bryan L Mcguckin, Bryce E Mansfield, Burnell M Henry, Calvin K Cook, Camilla S Smith, Carl A Huffman, III, Carmen Y Fisher, Caryn M Everly, Caryn M Mcnab, Cassandra Overking, Catherine J Laufmann, Catherine V Quinlan, CDR Kimberly Y Martin, Charles L Zhou, Charles M Spyr, Chava Kimchi Sarfaty, PhD, Christian D Lynch (CDL), Christine W Twohy, Clotia Cabbey Mensah, Cody D Rickman, Constantin Y Philopoulos, Corrine M Carter, Crystal M Young Lewis, Cynthia Jim, CSO, Dana D Carter, SR DDS, Danial S Hutchison, Daniel J Lahar, David L Miser, David S Cho, PhD, Dawn C Olenjack, Debara R Reese, Deborah A Nebenzahl, Deborah M Trout, Debra Boyd Seale, Denise L Burosh, Destry M Sillivan, Dina K West, Eboni S Funderburk, Edmund F Mrak, Jr, Edwin Melendez, Eileen A Liu, Elizabeth E Hart (ASCP), MT, Emest F Bizjak, Erika V Butler, Erma Zaimova, Everard A Irish, Farhana Khan, Felix Maldonado, Frederick M Lochner, Garrad R Poole, Gene D Arcy, Gerald B Seaborn, Jr, Ginger M Sykes, Grace E Mcnally, Hanna L Potter, Helen B Ricalde, Howard A Burmester, Humera T Khan, Ifueko Osemwota, Ingrid Y Johnson, Ismael Olvera, IV, J David Doleski, Jacqueline Mdiaz Albertini, James A Lane, James C Maclaughlin, James D Planchon, James R Evans, James R Fleckenstein, James R Montero, Jamie L Dion, Janae D Price, Janet L Bowen, Jazmine N Still, Jean Lhu Primmer, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A Hickey, Jennifer A Jones, Jennifer R Johnson, Jessica L Peterson, Jessie E Morris, Joan A Loreng, Joan A Loreno, John D Finkbohner, PhD, John M Mcinnis, Joseph R Strelnik, Joyce A Rockwell, Juan A Morales, Judith A Jankowski, Justin A Boyd, Kaarin M Slotte, Karen Emasley Joseph, Karen M Cooper, Karen M Labounty, Kathleen S Tormey, Kecia M Smith, Kelley L Clark, Kevin A Gonzalez, Kimberley A Hoefen, Kip J Hanks, L'oreal F Walker, Laura Fontan, MS, Laureen F Kononen, Laurel A Beer, Lauren A Crivellone, Lauren M Lilly, PhD, Laurie P Norwood, LCDR Debra Emerson, Leeterry Moore, Leigh Anne Myers, Lequita M Mayhew, Lesley Maep Lutao, Lily Y Koo, Linda Thai, Lisa M Thursam, Lisa P Oakes, Lori P Peters, Lynn L Wong, Maira P Brading, Marc A Jackson, Jr, Marcus L Head, Margaret Torres Vazquez, Margarita Santiago, Marianne Allen, Marie Bbuen Bigornia, Marijo B Kambere, PhD, Marion D Wimberly, Jr, Marion Michaelis, Marion W Nadeau, Mariza M Jafary, Mark A Elengold, Mark I Kaspar, Marlon K Turner, Mary Ann Ruff, Mary E Storch, Matthew J Gretkierewicz, Matthew J Sienko, Matthew R Dionne, Matthew R Sleeter, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melissa D Kalik, Melissa J Holz, Michael D Robinson, Michael I Gorman, Michael J Kuchta, Michael P Sheehan, Michael R Goga, Michael Y Philopoulos, Michele L Forster, PhD, Mihaly S Ligmond, Minerva Rogers, Misty D Harvey, Monique M Brooks, Mra Munizn, Muna Algharibeh, Myra K Casey, Nancy A Saxenian Emmons, Nancy L Neiger, Natalya M Ananyeva, Nerizza B Guerin, Nicholas Obiri, PhD, Nicole K Trudel, Noreen Muniz, Omatunde O Osunsamni, Omotunde O Osunsanmi, Patricia A Mcilroy, Patricia D Stahnke, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul A Bonneau, Paul M Kawamoto, Paula A Trost, Pawan K Jain, Philip E Ake, Prabhu P Raju, Randa Melhem, PhD, Rebecca E Dombrowski, Rebecca K Olin, Reginald Walker, Richard H Penta, Ricki A Chase, Ricki Achase Off, Robert C Coleman, Robert J Nesselhauf, Robert M Barbosa, Robert W Jennings, Roberta W Cunningham, Robin Levis, PhD, Roman Drews, PhD, Rose Ashley, Rose M Ashley, Russell K Riley, Samuel W Labinjo, Santiago Gallardo Johnson, Sarah A Palmer, Satheesh Thomas, Scott E Norris, Scott T Ballard, Sean R Bryd, Shafiq S Ahadi, Sharon I Gundersen, Sharon K Thoma, PharmD, Sherri J Jackson, Simone E Pitts, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen R Souza, Steven A Rubin, Steven C Madzo, Steven E Bowen, PhD, Steven P Donald, Steven P Eastham, Susan F Laska, MS, Susan M Jackson, Susan M Miller, Susan M North, Susan P Bruederle, Susan Yu, Susant Hadman, Svetlana A Shestopal, Tania Y Hall, Telicia R White, Thai D Truong, Theressa B Smith, Thomas J Arista, Tiara Nbrown Crosen, Tracy R Ball, Travis S Bradley, Unnee Ranjan, Uruaku A Obasi, Uttaniti Limchumroon (Tom), Vera M Anderson, Vickie J Kanion, Wayne E Seifert, Wayne W Grundstrom, Wei Wang, PhD, William F Lagud, Jr, William R Brubaker, Xiaojun Yan, Xiaokuang Lai, PhD, Xiaoping Guan, Zhong Li, PhD, Zhongren Wu

Lewis K Antwi's Documents

Publish Date Document Type Title
December, 2021 FDA 483 Bio-Rad Laboratories, Inc. - Form 483, 2021-12-13
July, 2018 FDA 483 Biostorage Technologies, Inc. - Form 483, 2018-07-06
March, 2019 FDA 483 Cade Medical, Inc. - Form 483, 2019-03-06
February, 2018 EIR Biomat USA, Inc. - EIR, 2018-02-01
March, 2022 FDA 483 National Genetics Institute - Form 483, 2022-03-02
April, 2021 FDA 483 SURGENEX LLC - Form 483, 2021-04-16
March, 2019 FDA 483 Bernz Medical Sales LLC - Form 483, 2019-03-11
August, 2023 FDA 483 Response Emergent Biodefense Operations Lansing LLC - Form 483R, 2023-09-07
July, 2019 FDA 483 Medscript Compounding Pharmacy - Form 483, 2019-07-17
November, 2016 FDA 483 Response Merrill D. Benson, M.D. - Form 483R, 2016-11-30
November, 2016 FDA 483 Merrill D. Benson, M.D. - Form 483, 2016-11-10
November, 2016 EIR Merrill D. Benson, M.D. - EIR, 2016-11-10
June, 2021 EIR Novartis Gene Therapies, Inc. - EIR, 2021-06-16
February, 2020 FDA 483 Institute for Human Reproduction (IHR), SC - Form 483, 2020-02-25
April, 2022 FDA 483 BAXALTA US INC. - Form 483, 2022-04-07
June, 2019 FDA 483 Indiana University Health - Form 483, 2019-06-12
February, 2020 FDA 483 Davies Fertility & IVF Specialists - Form 483, 2020-02-21
June, 2021 FDA 483 Novartis Gene Therapies, Inc. - Form 483, 2021-06-16
December, 2018 FDA 483 BioLife Plasma Services, L.P. - Form 483, 2018-12-13
June, 2021 FDA 483 Response Novartis Gene Therapies, Inc. - Form 483R, 2021-07-09
August, 2023 FDA 483 Brammer Bio MA, LLC - Form 483, 2023-08-30
March, 2019 FDA 483 Clinical Laboratories of HI at Wilcox Mem Hospital (Lab) - Form 483, 2019-03-14
November, 2022 FDA 483 University of Massachusetts Incorporated - Form 483, 2022-11-01
February, 2018 FDA 483 Biomat USA, Inc. - Form 483, 2018-02-01
November, 2022 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2022-11-18
August, 2023 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2023-08-16
August, 2019 FDA 483 Versiti Illinois Inc - Form 483, 2019-08-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more